Home
>
National Drug Code (NDC)
>
Hydromorphone Hydrochloride
Hydromorphone Hydrochloride - 0703-0110-03 - (HYDROMORPHONE HYDROCHLORIDE)
Drug Information of Hydromorphone Hydrochloride
| Product NDC: | 0703-0110 |
| Proprietary Name: | Hydromorphone Hydrochloride |
| Non Proprietary Name: | HYDROMORPHONE HYDROCHLORIDE |
| Active Ingredient(s): | 10 mg/mL & nbsp; HYDROMORPHONE HYDROCHLORIDE |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Hydromorphone Hydrochloride
| Product NDC: | 0703-0110 |
| Labeler Name: | Teva Parenteral Medicines, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078591 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110118 |
Package Information of Hydromorphone Hydrochloride
| Package NDC: | 0703-0110-03 |
| Package Description: | 10 VIAL in 1 CARTON (0703-0110-03) > 1 mL in 1 VIAL (0703-0110-01) |
NDC Information of Hydromorphone Hydrochloride
| NDC Code | 0703-0110-03 |
| Proprietary Name | Hydromorphone Hydrochloride |
| Package Description | 10 VIAL in 1 CARTON (0703-0110-03) > 1 mL in 1 VIAL (0703-0110-01) |
| Product NDC | 0703-0110 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | HYDROMORPHONE HYDROCHLORIDE |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Start Marketing Date | 20110118 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Parenteral Medicines, Inc. |
| Substance Name | HYDROMORPHONE HYDROCHLORIDE |
| Strength Number | 10 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |
